Clinical Trials Update: Oct. 5, 2006
Psoriasis and Psoriatic Disorders Rheumatoid Arthritis Sexual Dysfunction
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Psoriasis and Psoriatic Disorders
This study will evaluate an investigational topical treatment for body psoriasis in adolescents. Participants must have psoriasis on areas such as the arms, legs, chest, or back; adolescents who have scalp psoriasis but not body psoriasis will not be eligible. Six office visits, some requiring blood draws, with a board-certified dermatologist are required. Patients will receive free treatment for up to eight weeks, and may receive compensation for time and travel.
The research site is in San Diego, Calif.
This study will evaluate the effectiveness of an investigational medication in controlling symptoms of rheumatoid arthritis when taken in addition to methotrexate. Eligible volunteers at least 18 years old must active rheumatoid arthritis, must be taking 10 mg to 25 mg of methotrexate per week, and must have at least six tender joints and at least six swollen joints.
The research site is in Olean, NY.
This study will evaluate the effectiveness and safety of an investigational medication for hypoactive sexual desire disorder (HSDD). Participants will receive study medication, medical exams, and lab tests at no cost. Compensation for time and travel also may be available.
The research site is in Philadelphia, Penn.
Copyright 2006 Thomson CenterWatch. All rights reserved.